Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania

被引：192
作者：
Cavalli, Andrea [1 ,2 ]
Bolognesi, Maria Laura [1 ]
机构：
[1] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy
[2] Italian Inst Technol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2009年 / 52卷 / 23期
关键词：
HUMAN AFRICAN TRYPANOSOMIASIS; REDUCTASE-THYMIDYLATE SYNTHASE; FATTY-ACID SYNTHESIS; CHAGAS-DISEASE; DRUG DISCOVERY; VISCERAL LEISHMANIASIS; BRUCEI-RHODESIENSE; SLEEPING SICKNESS; NATURAL-PRODUCTS; METAL-COMPLEXES;
D O I：
10.1021/jm9004835
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：7339 / 7359
页数：21
相关论文
共 180 条
  • [1] Genomic-scale prioritization of drug targets: the TDR Targets database
    Agueero, Fernan
    Al-Lazikani, Bissan
    Aslett, Martin
    Berriman, Matthew
    Buckner, Frederick S.
    Campbell, Robert K.
    Carmona, Santiago
    Carruthers, Ian M.
    Chan, A. W. Edith
    Chen, Feng
    Crowther, Gregory J.
    Doyle, Maria A.
    Hertz-Fowler, Christiane
    Hopkins, Andrew L.
    McAllister, Gregg
    Nwaka, Solomon
    Overington, John P.
    Pain, Arnab
    Paolini, Gala V.
    Pieper, Ursula
    Ralph, Stuart A.
    Riechers, Aaron
    Roos, David S.
    Sali, Andrej
    Shanmugam, Dhanasekaran
    Suzuki, Takashi
    Van Voorhis, Wesley C.
    Verlinde, Christophe L. M. J.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (11) : 900 - 907
  • [2] On the origin, evolution, and nature of programmed cell death: a timeline of four billion years
    Ameisen, JC
    [J]. CELL DEATH AND DIFFERENTIATION, 2002, 9 (04) : 367 - 393
  • [3] O-alkoxyamidine prodrugs of furamidine:: In vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection
    Ansede, JH
    Anbazhagan, M
    Brun, R
    Easterbrook, JD
    Hall, JE
    Boykin, DW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (17) : 4335 - 4338
  • [4] Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations
    Aperis, George
    Mylonakis, Eleftherios
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (06) : 579 - 602
  • [5] Drug hybrids enter the fray
    Arnaud, Celia Henry
    [J]. CHEMICAL & ENGINEERING NEWS, 2007, 85 (46) : 46 - +
  • [6] Inactivation of parasite cysteine proteinases by the NO-donor 4-(phenylsulfonyl)-3-((2-(dimethylamino)ethyl)thio)-furoxan oxalate
    Ascenzi, P
    Bocedi, A
    Gentile, M
    Visca, P
    Gradoni, L
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1703 (01): : 69 - 77
  • [7] Molecular Basis of Antimony Treatment in Leishmaniasis
    Baiocco, Paola
    Colotti, Gianni
    Franceschini, Stefano
    Ilari, Andrea
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2603 - 2612
  • [8] Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo
    Balasegaram, Manica
    Harris, Steve
    Checchi, Francesco
    Hamel, Catherine
    Karunakara, Unni
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (10) : 777 - 782
  • [9] Network biology:: Understanding the cell's functional organization
    Barabási, AL
    Oltvai, ZN
    [J]. NATURE REVIEWS GENETICS, 2004, 5 (02) : 101 - U15
  • [10] Antimalarial dosing regimens and drug resistance
    Barnes, Karen I.
    Watkins, William M.
    White, Nicholas J.
    [J]. TRENDS IN PARASITOLOGY, 2008, 24 (03) : 127 - 134
12345678910